MALT lymphoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
(Mahshid) |
Ahmed Younes (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{MALT lymphoma}} | {{MALT lymphoma}} | ||
{{CMG}}{{AE}}{{SR}} | {{CMG}}{{AE}}{{SR}}, {{AY}} | ||
==Overview== | ==Overview== |
Latest revision as of 19:08, 18 December 2017
MALT lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
MALT lymphoma secondary prevention On the Web |
American Roentgen Ray Society Images of MALT lymphoma secondary prevention |
Risk calculators and risk factors for MALT lymphoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2], Ahmed Younes M.B.B.CH [3]
Overview
Secondary prevention strategies following MALT lymphoma include urease breath test, performed 4-6 weeks after completion of the course of antibiotic therapy, and endoscopy with concurrent biopsy, performed 3-6 months after the treatment is finished.[1]
Secondary Prevention
Secondary prevention strategies following MALT lymphoma include:[1]
- 4-6 weeks after completion of the course of antibiotic therapy for eradication of H.pyroli, urease breath test is performed to check for H. pylori.
- 3–6 months after the treatment has finished, endoscopy is performed. Biopsy is also performed simultaneously to confirm the eradication of H. pyroli infection and to assess whether the lymphoma is decreasing. The endoscopy is then performed every 4-6 months, eventually dropping to once a year.
References
- ↑ 1.0 1.1 Non-gastric lymphomas – causes, symptoms and treatments. Lymphoma association 2016. https://www.lymphomas.org.uk/sites/default/files/pdfs/Non-Gastric-malt-lymphoma.pdf. Accessed on January 28, 2016